315700
California Health in All Policies Task Force: From a start-up to an established institution
This presentation focuses on the opportunities and challenges that have arisen as the Task Force has moved to an institutionalized body, including a discussion of programmatic work, sustainability, and evaluation. Over the last three years, the Task Force has been carrying out 8 programmatic workplans that are now complete or nearly complete. This presentation will explore the opportunities that have arisen as a result and discuss how the Task Force has been able to develop and institutionalize a method for renewing projects, and deepening the work as trust grows between partners. The presentation will also discuss how the Task Force has maintained institutional knowledge and momentum in the midst of administration changes, staff turnover, and the addition of new Task Force agencies. Finally, the presentation will explore the challenges of evaluating collaborative, long-term policy work and describe how the Task Force is currently approaching evaluation.
Learning Areas:
Administration, management, leadershipImplementation of health education strategies, interventions and programs
Public health or related public policy
Social and behavioral sciences
Systems thinking models (conceptual and theoretical models), applications related to public health
Learning Objectives:
Describe at least 2 mechanisms for institutionalizing Health in All Policies.
List at least 3 key considerations in sustaining a Health in All Policies initiative.
List at least 3 key considerations in evaluating a Health in All Policies initiative.
Keyword(s): Policy/Policy Development, Partnerships
Qualified on the content I am responsible for because: I have served as the Program Director for the California Health in All Policies Task Force for the last two years. I have spoken locally, nationally, and internationally about this work as a subject matter expert.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.